Browsing Tag
FDA
293 posts
Hikma Pharmaceuticals partners with Emergent BioSolutions to expand access to KLOXXADO nasal spray
Hikma Pharmaceuticals PLC has announced an exclusive partnership with Emergent BioSolutions to commercialise KLOXXADO (naloxone HCl) nasal spray…
FDA accepts application for LEQEMBI subcutaneous dosing: A step forward in Alzheimer’s care
Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has accepted…
Corcept Therapeutics submits FDA application for relacorilant to treat Cushing’s syndrome
Corcept Therapeutics Incorporated has taken a significant step in addressing the unmet needs of patients with hypercortisolism, commonly…
Understanding rheumatoid arthritis: Symptoms, diagnosis, and comprehensive management
Rheumatoid arthritis is a chronic autoimmune disorder that predominantly affects joints, causing pain, swelling, stiffness, and eventual damage…
Sanofi strengthens cardiovascular portfolio with Aficamten rights in Greater China
Cytokinetics, Incorporated (NASDAQ: CYTK) saw its shares climb by 4.8% after announcing a landmark agreement with Sanofi (NASDAQ:…
Omeros stock skyrockets as narsoplimab improves survival in pivotal TA-TMA trial
Omeros Corporation, a Seattle-based biopharmaceutical company, is making waves after releasing results from its pivotal clinical trial for…
FDA acceptance propels Tonix Pharmaceuticals’ TNX-102 SL towards fibromyalgia treatment approval
Tonix Pharmaceuticals Holding Corp. has achieved a pivotal milestone with the FDA acceptance announcement for its New Drug…
Cumberland Pharmaceuticals announces FDA approval for Acetadote’s simplified dosing regimen
Shares of Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) surged in after-hours trading following the announcement that the U.S. Food…
Galderma’s nemolizumab sets new standard in prurigo nodularis treatment with OLYMPIA 1 trial success
Galderma’s latest clinical trial has unveiled a significant breakthrough in treating prurigo nodularis, a chronic neuroimmune skin condition…
Applied Therapeutics stock collapses as FDA rejects govorestat for galactosemia treatment
Shares of Applied Therapeutics, Inc. (Nasdaq: APLT) suffered a dramatic decline after the U.S. Food and Drug Administration…